4//SEC Filing
TANG CAPITAL PARTNERS LP 4
Accession 0001209191-20-057304
CIK 0001671584other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:47 PM ET
Size
38.1 KB
Accession
0001209191-20-057304
Insider Transaction Report
Form 4
TANG KEVIN C
10% Owner
Transactions
- Purchase
Common Stock
2020-11-04$13.83/sh+160,000$2,212,800→ 640,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-04$13.11/sh+88,379$1,158,649→ 480,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$14.22/sh+77,133$1,096,831→ 1,197,133 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$23.79/sh+171,626$4,082,983→ 1,440,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$20.94/sh+8,482$177,613→ 1,585,723 total(indirect: By LP) - Purchase
Common Stock
2020-11-06$20.63/sh+34,044$702,328→ 1,619,767 total(indirect: By LP) - Purchase
Common Stock
2020-11-06$23.48/sh+107,901$2,533,515→ 1,757,350 total(indirect: By LP) - Purchase
Common Stock
2020-11-04$10.63/sh+68,296$725,986→ 391,621 total(indirect: By LP) - Purchase
Common Stock
2020-11-04$13.65/sh+99,854$1,363,007→ 739,854 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$20.78/sh+137,241$2,851,868→ 1,577,241 total(indirect: By LP) - Purchase
Common Stock
2020-11-06$22.33/sh+29,682$662,799→ 1,649,449 total(indirect: By LP) - Purchase
Common Stock
2020-11-06$23.87/sh+2,650$63,256→ 1,760,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-04$16.33/sh+60,146$982,184→ 800,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-04$16.84/sh+160,000$2,694,400→ 960,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$15.31/sh+160,000$2,449,600→ 1,120,000 total(indirect: By LP) - Purchase
Common Stock
2020-11-05$15.32/sh+71,241$1,091,412→ 1,268,374 total(indirect: By LP)
Footnotes (17)
- [F1]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $10.11 to $11.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 17 herein.
- [F10]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.98 to $15.50.
- [F11]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.09 to $24.00.
- [F12]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.18 to $21.00.
- [F13]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.86 to $21.00.
- [F14]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.10 to $21.00.
- [F15]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.84.
- [F16]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $22.85 to $23.84.
- [F17]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.85 to $23.87.
- [F2]The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.
- [F3]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $12.88 to $13.44.
- [F4]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.33 to $14.00.
- [F5]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.18 to $14.00.
- [F6]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.18 to $16.45.
- [F7]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.33 to $17.00.
- [F8]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.74 to $15.50.
- [F9]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.98 to $14.93.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001191935
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:47 PM ET
- Size
- 38.1 KB